Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury.
Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury.
复制标题
创伤性脑损伤神经行为后遗症的药物治疗指南。
作者：
D. Warden;B. Gordon;T. McAllister;J. Silver;J. T. Barth;J. Bruns;A. Drake;Tony Gentry;A. Jagoda;D. Katz;J. Kraus;L. Labbate;L. M. Ryan;M. Sparling;B. Walters;J. Whyte;Ashley Zapata;G. Zitnay
There is currently a lack of evidence-based guidelines to guide the pharmacological treatment of neurobehavioral problems that commonly occur after traumatic brain injury (TBI). It was our objective to review the current literature on the pharmacological treatment of neurobehavioral problems after traumatic brain injury in three key areas: aggression, cognitive disorders, and affective disorders/anxiety/ psychosis. Three panels of leading researchers in the field of brain injury were formed to review the current literature on pharmacological treatment for TBI sequelae in the topic areas of affective/anxiety/ psychotic disorders, cognitive disorders, and aggression. A comprehensive Medline literature search was performed by each group to establish the groups of pertinent articles. Additional articles were obtained from bibliography searches of the primary articles. Group members then independently reviewed the articles and established a consensus rating. Despite reviewing a significant number of studies on drug treatment of neurobehavioral sequelae after TBI, the quality of evidence did not support any treatment standards and few guidelines due to a number of recurrent methodological problems. Guidelines were established for the use of methylphenidate in the treatment of deficits in attention and speed of information processing, as well as for the use of beta-blockers for the treatment of aggression following TBI. Options were recommended in the treatment of depression, bipolar disorder/mania, psychosis, aggression, general cognitive functions, and deficits in attention, speed of processing, and memory after TBI. The evidence-based guidelines and options established by this working group may help to guide the pharmacological treatment of the person experiencing neurobehavioral sequelae following TBI. There is a clear need for well-designed randomized controlled trials in the treatment of these common problems after TBI in order to establish definitive treatment standards for this patient population.
登录
查看更多内容
头部受伤、双相情感障碍和对丙戊酸钠的反应。
影响因子：
7.3
作者：
PopeJr,HG;McElroy,SL;Satlin,A;Hudson,JI;KeckJr,PE;Kalish,R
通讯作者：
Kalish,R
DOI：
10.1001/jama.1991.03460100073027
发表时间：
1991-03
期刊：
JAMA
影响因子：
--
作者：
S. Dikmen;N. Temkin;Bonnie Miller;J. Machamer;H. Winn
通讯作者：
S. Dikmen;N. Temkin;Bonnie Miller;J. Machamer;H. Winn
DOI：
10.1176/ajp.143.1.35
发表时间：
1986
期刊：
The American journal of psychiatry
影响因子：
--
作者：
S. Yudofsky;J. Silver;W. Jackson;J. Endicott;D. Williams
通讯作者：
S. Yudofsky;J. Silver;W. Jackson;J. Endicott;D. Williams
哌醋甲酯对脑外伤后注意力功能的影响。
DOI：
10.1097/00002060-199711000-00002
发表时间：
1997
影响因子：
3
作者：
Whyte,J;Hart,T;Schuster,K;Fleming,M;Polansky,M;Coslett,HB
通讯作者：
Coslett,HB
哌醋甲酯对创伤性脑损伤后注意力缺陷的影响：一项多维、随机、对照试验。
DOI：
10.1097/01.phm.0000128789.75375.d3
发表时间：
2004
影响因子：
3
作者：
Whyte,John;Hart,Tessa;Vaccaro,Monica;Grieb-Neff,Patricia;Risser,Anthony;Polansky,Marcia;Coslett,HBranch
通讯作者：
Coslett,HBranch